4-(3-Chlorophenyl)-4-oxobutyric acid, 95.0%, 100mg

4-(2-Bromoethyl)morpholine hydrobromide, 95.0%, 250mg

3-[[2-(Methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonate>98.0%(T)(N)100g

Poudre d'oxyde de silicium(IV) 99,99% 250 g

(S)-TETRAHYDROFURAN-3-YL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYL-3-(PHOSPHONOOXY)BUTAN-2-YL)CARBAMATE, 99%, 1mg

methyl 7-methylpyrazolo[1,5-a]pyrimidine-5-carboxylate, 95%, 1g

Allyltriphenylphosphonium bromide, 95.0%, 500g

1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone, 95.0%, 50mg

Récipients à échantillons Récipient à échantillons avec fermeture à vis, non stérile, 200 pièce(s)

2-(3,4-DIAMINOPHENYL)ACETIC ACID, 95.0%, 250mg

4-Bromo-1H-indole-6-carbonitrile, 95.0%, 10g

tert-Butyl N-[1-(4-fluorophenyl)cyclopropyl]carbamate, 95.0%, 250mg

1-(3-chloropropanoyl)-3-methylpiperidine, 95.0%, 1g